ECL SEC Filings

Ecolab Inc. (ECL) filed an 8-K on February 10, 2026, primarily to announce updates regarding its financial condition and a significant restructuring initiative. While the filing doesn't detail fourth quarter 2025 earnings, it incorporates by reference a news release and supplemental data that do. Investors should note the expansion of the "One Ecolab" initiative, which includes a substantial restructuring plan aimed at leveraging digital technologies and creating global centers of excellence. This plan is expected to incur significant costs but is positioned as a driver for future growth and margin expansion.

Ecolab Inc. reported a net sales increase of 4% to $4,165.0 million for the third quarter of 2025, reaching $11,885.2 million for the first nine months, a 1% increase year-over-year. While reported operating income saw a significant decrease of 27% in the third quarter due to a large gain on the sale of its global surgical solutions business in the prior year, adjusted operating income showed a healthy 10% increase. Net income attributable to Ecolab decreased by 21% to $585.0 million in the third quarter, but adjusted net income saw a 13% increase. Diluted EPS also reflected this trend, with reported EPS down 21% but adjusted diluted EPS up 13%. The company continues to invest in growth initiatives, as evidenced by increased SG&A expenses relative to sales in the third quarter. The "One Ecolab" initiative is progressing, with expanded restructuring plans anticipated to yield significant cost savings. Ecolab also announced its agreement to acquire Ovivo Electronics for approximately $1.8 billion, signaling a strategic move into the semiconductor manufacturing water technology sector. The company maintains a strong balance sheet with increased cash and cash equivalents, and its leverage ratios remain stable.

Ecolab Inc. (ECL) has filed an 8-K report on October 28, 2025, announcing its financial results for the third quarter ended September 30, 2025. The filing primarily serves to attach and incorporate by reference the press release and supplemental data related to these results. Investors should refer to Exhibit 99.1 (News Release) and Exhibit 99.2 (Supplemental Data) for detailed financial performance, operational updates, and forward-looking statements. The company's announcement provides the market with its latest performance figures, which are crucial for assessing the company's trajectory and making informed investment decisions. While the 8-K itself is a procedural filing, the attached exhibits contain the substantive information regarding Ecolab's financial condition and results of operations for the third quarter.

Ecolab Inc. (ECL) has filed an 8-K detailing the successful completion of a public offering of $500 million aggregate principal amount of 5.000% Notes due 2035. The offering, underwritten by Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC, was completed on August 27, 2025. The net proceeds from this issuance are intended for general corporate purposes, which may include funding a portion of the previously announced acquisition of Ovivo Inc.’s Electronics business and repaying outstanding commercial paper or other debt. This debt issuance provides Ecolab with significant capital to execute its strategic growth initiatives and manage its existing financial obligations.

Ecolab Inc. (ECL) reported solid financial results for the second quarter and first six months of 2025. Net sales saw a modest increase of 1% year-over-year, reaching $4,025.2 million for the quarter, with organic sales up 3%. This growth was driven by increases across most of its reporting segments, including Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences, underscoring the company's ability to maintain pricing power and expand its market reach. Profitability showed a notable improvement, with reported operating income increasing by 8% to $710.1 million for the quarter. Net income attributable to Ecolab rose by 7% to $524.2 million. The company also highlighted strong performance in adjusted metrics, with adjusted diluted EPS increasing by 13% to $1.89, reflecting effective cost management and operational efficiencies, particularly from the 'One Ecolab' initiative. The balance sheet remains robust, with a strong cash position and manageable debt levels, supporting ongoing capital expenditures and shareholder returns.

Ecolab Inc. (ECL) has announced a significant addition to its Board of Directors with the appointment of Julie P. Whalen, effective August 6, 2025. Ms. Whalen brings a wealth of financial expertise, having previously served as Executive Vice President and Chief Financial Officer for Expedia Group, Inc. and Williams-Sonoma, Inc. Her extensive experience in financial planning, corporate control, treasury, and audit committee leadership, including her tenure as Chair of Expedia's Audit Committee, is expected to be a valuable asset to Ecolab's governance and strategic direction. Ms. Whalen's appointment to the Board, as well as her placement on the Audit and Finance Committees, underscores the company's commitment to robust financial oversight and strategic financial management. Her qualifications as a Certified Public Accountant and her Juris Doctor degree further enhance her suitability for these critical roles. Investors should view this appointment as a positive development, indicating a focus on strengthening the company's financial acumen at the highest levels of leadership.

Ecolab Inc. (ECL) has filed an 8-K report on July 29, 2025, to announce its financial results for the second quarter ended June 30, 2025. The filing incorporates by reference the company's official press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) used in conjunction with its conference call. These documents provide detailed insights into the company's performance during the quarter. Investors should refer to the furnished exhibits, which will also be available on Ecolab's website, for comprehensive financial and operational details. While this 8-K primarily serves as an announcement mechanism for the earnings release and supplemental information, it signifies a key update on the company's ongoing financial condition and operational results.

Ecolab Inc. (ECL) has announced the resignation of its Executive Vice President and Chief Supply Chain Officer, Machiel Duijser, effective July 25, 2025. Mr. Duijser is departing to pursue a senior executive role at another publicly traded company. Importantly, the company states that his resignation is not a result of any disagreements regarding Ecolab's operations, policies, or practices. This indicates a voluntary departure, which is generally viewed favorably by investors as it avoids potential signs of internal turmoil. Investors should note that Ecolab has a succession plan in place and will be appointing an internal successor for this critical role. While the name of the successor is not yet disclosed in this filing, the emphasis on an internal appointment suggests continuity and a stable leadership transition. The supply chain function is vital for a company like Ecolab, and the market will likely be watching closely to see how this leadership change impacts operational efficiency and future strategic execution.

Ecolab Inc. (ECL) has announced the completion of a $500 million offering of its 4.300% Notes due 2028. The net proceeds from this issuance are designated for general corporate purposes, which may include the repayment of existing indebtedness. This debt offering, executed through an underwriting agreement with several representatives including Barclays Capital Inc. and BofA Securities, Inc., was made under the company's existing shelf registration statement. The notes bear a semi-annual interest rate of 4.300% and mature on June 15, 2028. This financing activity indicates Ecolab's ongoing capital management strategy. Investors should note the stated use of proceeds, which could signal a deleveraging effort or funding for general operational needs. The inclusion of standard covenants within the indenture provides some investor protections, such as limitations on liens and sale-and-leaseback transactions, and a provision for a mandatory repurchase offer in the event of a change of control.

Ecolab Inc. filed an 8-K on May 8, 2025, reporting on key events and outcomes from its Annual Meeting of Stockholders held on May 8, 2025. A significant development was the appointment of Marion K. Gross to the Board of Directors, effective May 7, 2025, and her subsequent election by stockholders at the Annual Meeting. Ms. Gross brings extensive supply chain and sustainability leadership experience from McDonald's, and her appointment is expected to enhance the Board's expertise. Furthermore, Ecolab's stockholders approved proposed amendments to the Restated Certificate of Incorporation, which aim to limit the liability of certain officers, aligning with Delaware law. The company also reported the election of 13 directors, the advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as its independent auditor for fiscal year 2025. These announcements provide insights into corporate governance and operational continuity for investors.

Ecolab Inc. (ECL) has filed an amendment to its prior 8-K filing to provide updated information regarding committee appointments for its Board of Directors. Specifically, Michel Doukeris, who was appointed to the Board on February 20, 2025, has now been assigned to the Audit Committee and the Governance Committee. These appointments are effective as of May 8, 2025. While this filing does not contain new financial results or material strategic changes, it provides clarity on the board's governance structure. Investors can note that Mr. Doukeris, a key executive, is now integrated into important board oversight functions, including financial reporting oversight (Audit Committee) and corporate governance practices (Governance Committee). This reflects a standard practice for onboarding new board members into key committee roles.

Ecolab Inc. reported first-quarter 2025 results with net sales of $3,695.0 million, a 2% decrease compared to the prior year, primarily due to the divestiture of the global surgical solutions business and unfavorable currency translation. However, on a fixed currency basis, net sales increased by 1%, and organic sales grew by 3%. The company's operating income saw a healthy increase of 7% to $555.3 million, driven by strong organic growth across its segments and improved pricing strategies. Net income attributable to Ecolab was $402.5 million, a slight decrease of 2% year-over-year, while diluted EPS stood at $1.41. The company continues to make progress on its 'One Ecolab' initiative, which is designed to enhance growth and margin expansion, with significant restructuring charges impacting the current quarter. Despite these charges and ongoing macroeconomic uncertainties, Ecolab's diversified business model and focus on value pricing have supported its performance. Investors will be watching the execution of the 'One Ecolab' plan and its impact on future profitability and cash flow generation.

Ecolab Inc. (ECL) has filed an 8-K report on April 29, 2025, to announce its first-quarter financial results for the period ending March 31, 2025. While the 8-K itself does not contain the detailed financial figures, it explicitly references the accompanying News Release (Exhibit 99.1) and Supplemental Data (Exhibit 99.2) as the primary sources for this information. Investors should refer to these attached exhibits for a comprehensive understanding of Ecolab's performance during the first quarter of 2025. These exhibits, which are furnished with the report and will also be available on Ecolab's website (www.ecolab.com), are crucial for analyzing the company's operational and financial condition. The filing indicates that the company will hold a conference call to discuss these first-quarter results, further emphasizing the importance of the information contained within the referenced documents.

Ecolab Inc. (ECL) has filed a Current Report on Form 8-K to provide investors with supplemental unaudited reportable segment information for the years ended December 31, 2024, and December 31, 2023. This filing includes data presented at fixed currency exchange rates established at the beginning of 2025, which aims to offer a clearer view of underlying business performance without the impact of currency fluctuations. Additionally, Ecolab is detailing significant changes to its segment reporting structure, effective from the first quarter of 2025. These segment realignments include renaming the Global Industrial segment to Global Water and incorporating specific sub-segments. The healthcare operating segment has been moved into the Institutional operating segment, and Global Life Sciences has been elevated to a standalone reportable segment. Investors should note that this information is supplemental and does not replace previously filed financial statements, but it provides valuable context for understanding the company's evolving operational structure and performance metrics.

Ecolab Inc. (ECL) announced on March 27, 2025, that it has entered into a fourth amended and restated multicurrency credit agreement, establishing a new $2.0 billion unsecured 5-year revolving credit facility that matures in March 2030. This new facility replaces and extends the maturity of Ecolab's previous $2.0 billion credit facility, which was set to expire in April 2026. The primary purpose of this enhanced credit facility is to provide financial flexibility for general corporate purposes, including potential share repurchases, debt repayment, and strategic acquisitions. The agreement, with Bank of America, N.A. as administrative agent, offers various interest rate options for U.S. Dollar, Euro, Yen, and Sterling denominated loans, incorporating benchmarks like Term SOFR, EURIBOR, TIBOR, and SONIA. It also includes subfacilities for letters of credit and swing line loans. A key aspect for investors to note is the inclusion of a financial covenant requiring Ecolab to maintain a minimum interest expense coverage ratio, alongside customary covenants and events of default. This strategic move underscores Ecolab's commitment to maintaining robust liquidity and financial maneuverability.

Ecolab Inc. (ECL) reported strong financial performance for the fiscal year ended December 31, 2024, with record sales, operating income margin, free cash flow, and adjusted diluted earnings per share. The company achieved this through robust value pricing, lower delivered product costs, and increased volumes across its diverse segments, including Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. Key financial highlights include a 3% increase in reported sales to $15.7 billion and a significant 41% increase in reported operating income to $2.8 billion. Adjusted diluted EPS grew by 28% to $6.65. Ecolab also demonstrated a strong commitment to shareholder returns, increasing its quarterly cash dividend by 14% and maintaining a solid balance sheet with "A" range credit rating metrics. The company continues to invest in its business, evidenced by capital expenditures and strategic acquisitions, while also focusing on sustainability initiatives with ambitious GHG emission reduction goals.

Ecolab Inc. announced a significant change to its Board of Directors through an 8-K filing on February 20, 2025. The company appointed Michel Doukeris, the current Chief Executive Officer of Anheuser-Busch InBev SA/NV, as a new director. Mr. Doukeris brings extensive global leadership experience, particularly in commercial operations and leading large markets, which could offer valuable strategic insights to Ecolab's future growth and operational strategies. In addition to the new appointment, the filing also disclosed that director Arthur J. Higgins will not be seeking re-election at the upcoming annual meeting. While the departure is stated to be unrelated to any disagreements, it marks the end of Mr. Higgins' tenure, with the company expressing gratitude for his service. Investors should monitor how these board changes may influence future corporate governance and strategic direction.

Ecolab Inc. (ECL) has filed an 8-K report on February 11, 2025, to announce its fourth-quarter results for the period ended December 31, 2024. The filing primarily serves to furnish the company's earnings release (Exhibit 99.1) and supplemental data (Exhibit 99.2) which were made public on February 11, 2025. These documents, which are incorporated by reference into the 8-K, contain detailed financial information and operational highlights for the fourth quarter. Investors should refer to these attached exhibits for specific earnings figures, segment performance, and management's commentary on the financial condition and results of operations. While this 8-K does not contain new financial statements or other substantive disclosures beyond the earnings announcement, it formally communicates that the earnings release and supplementary data are available. Ecolab will also be publishing these exhibits on its corporate website, www.ecolab.com, for broader accessibility. The company has elected not to use the extended transition period for complying with new or revised financial accounting standards, as it is not an emerging growth company.

Ecolab Inc. (ECL) reported a strong third quarter for fiscal year 2024, demonstrating robust sales growth and significant improvements in profitability. Net sales increased by 1% to $3,998.5 million, with organic sales growing by 4%, indicating healthy underlying business momentum across its key segments. The company experienced notable margin expansion, with reported gross margin improving to 43.4% from 41.1% in the prior year period, driven by effective value pricing and lower delivered product costs. Profitability saw a substantial uplift, with reported operating income surging by 85% year-over-year to $1,044.8 million. Net income attributable to Ecolab more than doubled to $736.5 million, and diluted EPS rose by 83% to $2.58. These gains were bolstered by the significant gain on the sale of the global surgical solutions business, but even on an adjusted basis, the company showed solid growth, with adjusted diluted EPS increasing by 19%. Ecolab continues to execute on its strategic initiatives, including the 'One Ecolab' program aimed at driving growth and margin expansion, and maintains a strong liquidity position with substantial cash reserves and available credit facilities.

Ecolab Inc. (ECL) has filed an 8-K report on October 29, 2024, to announce its third-quarter financial results for the period ended September 30, 2024. The filing primarily serves to furnish the accompanying news release (Exhibit 99.1) and supplemental data (Exhibit 99.2) that were made public on October 29, 2024. These documents contain the detailed earnings information and will be available on Ecolab's website, offering investors insight into the company's recent performance. Investors should refer to the attached exhibits for specific financial metrics, including revenue, earnings per share, and any commentary from management regarding operational performance, segment results, and future outlook. The report does not contain new material business developments beyond the earnings announcement itself, but the supplemental data is likely to provide a deeper dive into key performance indicators and financial breakdowns relevant for valuation and strategic assessment.

Ecolab Inc. (ECL) reported strong financial results for the second quarter and first six months of 2024, demonstrating significant year-over-year growth in net sales and net income. Net sales increased by 3% to $3,985.8 million in the second quarter and 4% to $7,737.7 million for the first six months, driven by robust organic sales growth across key segments, particularly Global Institutional & Specialty and Global Pest Elimination. The company also saw a substantial increase in operating income, up 36% to $656.9 million for the quarter, reflecting improved gross margins due to lower supply chain costs and effective pricing strategies. The company successfully managed its cost of sales, leading to a notable improvement in gross margin to 43.8% in the second quarter of 2024, up from 39.4% in the prior year. Net income attributable to Ecolab surged by 49% to $490.9 million ($1.71 per diluted share) for the second quarter. This performance was bolstered by strategic initiatives and operational efficiencies, despite some ongoing restructuring costs. Ecolab also completed the sale of its global surgical solutions business on August 1, 2024, which is expected to result in a pre-tax gain.

Ecolab Inc. (ECL) has filed a Current Report (8-K) on July 30, 2024, primarily announcing its second-quarter 2024 results and a significant restructuring initiative. The company is launching the 'One Ecolab' initiative, aimed at enhancing growth and margin expansion. A key component of this initiative is a restructuring plan to centralize functional work into global centers of excellence, leveraging digital technologies. This plan is expected to incur substantial restructuring costs and special charges over the next few years. Investors should note the financial implications of the 'One Ecolab' initiative. Ecolab anticipates total restructuring costs of $175 million ($136 million after tax) and special charges of $50 million ($39 million after tax) by the end of 2027. These costs are largely expected to be cash expenditures, predominantly for severance related to team reorganization. While the report focuses on these forward-looking initiatives and financial impacts, the specific financial results for the second quarter of 2024 are referenced through attached press releases and supplemental data, which would require further review for detailed performance metrics.

Ecolab Inc. (ECL) filed an 8-K on May 6, 2024, detailing the results of its Annual Meeting of Stockholders held on May 2, 2024. The meeting saw strong support for the re-election of its 12-member Board of Directors and the ratification of PricewaterhouseCoopers LLP as its independent auditor for fiscal year 2024. Additionally, shareholders approved, on an advisory basis, the compensation of named executives. The meeting also addressed a shareholder proposal concerning an independent board chair policy, which did not receive majority support from the shareholders. This filing provides transparency on key corporate governance matters and shareholder voting outcomes.

Ecolab Inc. reported a strong first quarter for 2024, with net sales increasing by 5% year-over-year to $3.75 billion, driven by a 5% increase in organic sales. The company demonstrated significant profit growth, with reported operating income up 47% to $517.9 million and net income attributable to Ecolab soaring 77% to $412.1 million. This robust performance was supported by an improved gross margin of 43.3% (up from 38.3% in the prior year) due to lower delivered product costs and effective pricing strategies. The company's strategic focus on efficiency and pricing power appears to be paying off, leading to substantial earnings per share growth. Ecolab also managed its debt effectively, reducing total debt by approximately $630 million in the quarter and maintaining a healthy net debt to EBITDA ratio of 2.2. Looking ahead, Ecolab has agreed to sell its global surgical solutions business for $950 million, which is expected to close in the second half of 2024 and generate a pre-tax gain, further strengthening its financial position and allowing for continued strategic investments.

Ecolab Inc. (ECL) has filed an 8-K report on April 30, 2024, to announce its financial results for the first quarter ended March 31, 2024. The report primarily serves to furnish the accompanying earnings release and supplemental data, which are incorporated by reference and will be available on the company's website. While the 8-K itself does not contain detailed financial figures, it directs investors to these supplementary documents for a comprehensive understanding of the company's performance during the quarter. Investors should refer to Exhibit (99.1), the News Release, and Exhibit (99.2), the Supplemental Data, for specific details on Ecolab's first-quarter operational and financial condition. These attached exhibits are crucial for evaluating the company's recent performance, trends, and any forward-looking statements or guidance provided by management.

Ecolab Inc. (ECL) filed an 8-K on March 15, 2024, to provide supplemental unaudited segment net sales and operating income information for the years ended December 31, 2023, and December 31, 2022. This filing importantly includes data reflecting international operations at fixed currency exchange rates established at the beginning of 2024, offering a clearer view of underlying operational performance by neutralizing currency fluctuations. Investors should note that this information is supplemental and not intended to replace previously filed financial statements but provides additional context for evaluating segment performance. The filing also details significant changes to Ecolab's segment reporting structure, effective January 1, 2024. The former Textile Care and Colloidal Technologies Group (CTG) segments have been integrated into the Water operating segment, which remains within the Global Industrial reportable segment. Additionally, the Pest Elimination segment, previously aggregated, is now reported as a standalone Global Pest Elimination reportable segment. These adjustments result in a new structure with eight operating segments and are reflected in the supplemental data provided.

Ecolab Inc. (ECL) announced a significant executive transition with the resignation of Lanesha T. Minnix, Executive Vice President, General Counsel and Secretary. Ms. Minnix is departing on April 1, 2024, to assume a chief legal officer role at another public company. Importantly, her resignation is stated to be amicable and not due to any disagreements concerning Ecolab's operations, policies, or practices. This leadership change in a key legal role warrants investor attention regarding the continuity and future direction of the company's legal and corporate governance functions.

Ecolab Inc. reported a strong financial performance for the year ended December 31, 2023, with net sales increasing by 8% to $15.3 billion and reported diluted Earnings Per Share (EPS) rising by 26% to $4.79. This growth was driven by robust pricing strategies across all segments, which effectively offset continued increases in delivered product costs. The company's operating income saw a significant 28% increase, reflecting improved gross margins and disciplined cost management. The company continues to prioritize its "Circle the Customer – Circle the Globe" strategy, emphasizing sustainability and innovation. Ecolab's commitment to reducing water and energy usage for its customers remains a core tenet of its business model, with significant progress made towards its 2030 water conservation goals. The company maintained strong financial health with a healthy balance sheet and generated substantial operating cash flow, enabling continued investment in business growth, debt repayment, and shareholder returns through dividends and share repurchases.

Ecolab Inc. (ECL) has filed a Current Report (8-K) on February 22, 2024, primarily announcing a change in its Board of Directors. The company appointed Judson Althoff, Executive Vice President and Chief Commercial Officer of Microsoft Corporation, as a new director, effective February 21, 2024. Mr. Althoff's extensive experience in commercial business and technology leadership is expected to be a valuable asset to Ecolab's Board, and he will serve on the Audit and Finance Committees. In addition, the report notes that director Barbara J. Beck will not be standing for re-election at the upcoming annual meeting on May 2, 2024. Ms. Beck is stepping down for personal family reasons and not due to any disagreements with the company. The Board expressed gratitude for her service. These board changes are the main focus of this filing, with no significant financial or operational updates provided at this time.

Ecolab Inc. (ECL) filed an 8-K on February 13, 2024, to report its fourth-quarter and full-year 2023 financial results. The filing primarily serves as a notification of the earnings release and related supplemental data, which are attached as exhibits. Investors should refer to the furnished News Release (Exhibit 99.1) and Supplemental Data (Exhibit 99.2) for detailed financial performance, operational highlights, and forward-looking statements. These documents, available on Ecolab's website, provide the comprehensive information regarding the company's recent financial condition and results of operations.

Ecolab Inc. (ECL) reported strong third quarter and year-to-date results for 2023, demonstrating resilience and growth across its key segments. Net sales increased by 8% year-over-year for both the quarter and the nine-month period, reaching $3.96 billion and $11.38 billion, respectively. This growth was driven by a combination of solid pricing actions and modest volume increases, reflecting the company's ability to pass on costs and the demand for its essential products and services. Profitability saw a significant improvement, with reported operating income up 17% in the third quarter and 19% year-to-date. Diluted EPS also showed robust growth, increasing 17% for the quarter to $1.41 and 17% year-to-date to $3.38. The company's improved gross margin, up to 41.1% in the third quarter from 37.5% in the prior year, highlights effective cost management and pricing strategies. The company also made significant progress on its restructuring programs, driving further efficiencies and contributing to the overall improved financial performance.

Ecolab Inc. (ECL) filed an 8-K report on October 31, 2023, primarily announcing its third quarter financial results for the period ended September 30, 2023. The report itself is brief, serving as a cover for the attached news release (Exhibit 99.1) and supplemental data (Exhibit 99.2), which contain the detailed financial performance and operational highlights. Investors should refer to these attached exhibits for comprehensive information regarding the company's performance during the third quarter.

Ecolab Inc. reported solid financial results for the second quarter and first six months of 2023, demonstrating revenue growth and improved profitability. Net sales increased by 8% year-over-year for both periods, driven by a combination of price increases and volume growth across most segments. The company saw particular strength in its Global Industrial and Global Institutional & Specialty segments, which experienced double-digit organic sales growth. Profitability also improved, with reported operating income up 14% and 23% for the respective periods. The company is actively managing restructuring initiatives aimed at cost savings, with a significant portion of the anticipated charges expected to be completed by 2024. Despite ongoing inflationary pressures and global economic uncertainties, Ecolab maintained a strong financial position. The company's liquidity remains robust, supported by consistent cash flow from operations. Management is focused on strategic growth initiatives, including targeted acquisitions, while also returning capital to shareholders through dividends and share repurchases. Ecolab's diversified business model and disciplined approach to cost management position it well to navigate the current economic landscape.

Ecolab Inc. (ECL) filed an 8-K on August 1, 2023, to announce its second-quarter financial results for the period ending June 30, 2023. The filing primarily serves to incorporate by reference the company's earnings release (Exhibit 99.1) and supplemental data (Exhibit 99.2) that were issued on the same date. These attached documents contain the detailed financial performance and operational highlights for the quarter. Investors should refer to the furnished exhibits for comprehensive information on Ecolab's performance, including key financial metrics, segment performance, and management's commentary. While the 8-K itself is procedural, the attached earnings materials provide the substance of the company's quarterly update, which is crucial for understanding the current financial health and outlook of Ecolab.

Ecolab Inc. (ECL) filed an 8-K on May 23, 2023, reporting a significant change in its Board of Directors. Jeffrey M. Ettinger, who served as Lead Director for the past six years and was a member of the Compensation & Human Capital Management and Governance Committees, resigned from the Board effective May 23, 2023. This resignation is a direct consequence of his appointment as the Interim President of the University of Minnesota. The company expressed gratitude for Mr. Ettinger's contributions and leadership, particularly during his tenure as Lead Director. Importantly, the filing clarifies that Mr. Ettinger's departure was not a result of any disagreements with Ecolab. This information is crucial for investors to understand leadership transitions and governance matters within the company.

Ecolab Inc. (ECL) filed an 8-K on May 9, 2023, detailing the outcomes of its Annual Meeting of Stockholders held on May 4, 2023. The primary focus for investors revolves around the approval of key proposals, including the new Ecolab Inc. 2023 Stock Incentive Plan, which authorizes the issuance of up to 20,000,000 shares of common stock for employee and director compensation. Additionally, the company secured stockholder ratification for its independent auditor, PricewaterhouseCoopers LLP, for the fiscal year ending December 31, 2023. The meeting also saw the election of 13 directors, the approval of an amendment to the Stock Purchase Plan, and a majority vote in favor of the advisory resolution on executive compensation. Importantly, stockholders approved holding the advisory vote on executive compensation on an annual basis. However, a stockholder proposal seeking an independent board chair policy was not approved.

Ecolab Inc. reported strong first-quarter 2023 results, demonstrating resilience and growth in a dynamic economic environment. Net sales increased by 9% year-over-year to $3.57 billion, driven by a 13% increase in organic sales, indicating robust underlying business performance. This growth was primarily fueled by effective pricing strategies across all segments, which more than offset increased delivered product costs. The company's operating income saw a significant increase of 38% to $351.6 million, reflecting improved operational efficiencies and strong sales execution. The company's diversified business segments, including Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences, all contributed positively to the top-line growth, with particular strength noted in water treatment, food & beverage, and life sciences. Despite inflationary pressures and foreign currency headwinds, Ecolab maintained a disciplined approach to cost management and strategic investments, leading to a notable improvement in profitability. The company's balance sheet remains solid, with sufficient liquidity to support ongoing operations and strategic initiatives.

Ecolab Inc. (ECL) filed an 8-K on May 4, 2023, to report the immediate effectiveness of its Amended and Restated By-Laws, approved by its Board of Directors on May 3, 2023. These amendments are primarily to align the Company's governance documents with changes in the Delaware General Corporation Law (DGCL) and to enhance procedural clarity for stockholders and the Board. Key updates include refinements to adjournment procedures, stockholder list requirements, and consent procedures to reflect current DGCL provisions. The By-Laws also clarify quorum requirements for the Board, opt into specific DGCL sections regarding Board committees, and update advance notice provisions for director nominations and shareholder proposals. Additionally, changes were made to indemnification provisions, including expense advancements and the ability for indemnified individuals to sue for unpaid claims. These changes are designed to ensure compliance with legal standards and streamline corporate governance processes.

Ecolab Inc. (ECL) filed a Form 8-K on May 2, 2023, to report its first-quarter 2023 financial results. The filing primarily serves to provide access to the company's earnings release (Exhibit 99.1) and supplemental data (Exhibit 99.2) that were issued on the same date. These documents contain the detailed financial performance and operational insights for the quarter ended March 31, 2023. Investors should refer to the attached exhibits for comprehensive information on Ecolab's Q1 2023 performance, including revenue, earnings per share, segment performance, and any forward-looking guidance or strategic commentary provided by the company. The filing itself does not contain detailed financial tables but directs stakeholders to the furnished documents for material disclosures.

Ecolab Inc. (ECL) has filed a Current Report on Form 8-K on April 5, 2023, to provide investors with supplemental unaudited financial information related to its reportable segments for the years ended December 31, 2022 and 2021. This data is presented using fixed currency exchange rates established at the beginning of 2023, allowing for a clearer view of operational performance independent of currency fluctuations. Additionally, the report details immaterial changes to the company's segment reporting structure, notably the integration of the former Downstream segment into the Water operating segment, effective January 1, 2023. These adjustments result in a revised segment structure comprising ten operating segments. While this filing does not present new formal financial results, it offers valuable context for analyzing Ecolab's segment performance and understanding the impact of currency movements. Investors should note that this information is supplemental and furnished, not filed, and is intended to complement, not replace, the data provided in the company's official 10-Q and 10-K filings. The company will also publish these exhibits on its website.

Ecolab Inc. (ECL) reported strong top-line performance in its 2022 10-K filing, with reported sales increasing by 11% to $14.2 billion, driven by double-digit growth across most segments. This growth was fueled by significant pricing actions that effectively offset substantial increases in delivered product costs. While operating income remained stable, it was impacted by higher costs and strategic investments. The company's financial position remains robust, supported by an "A" range credit rating and strong cash flow generation, enabling continued investment in the business and shareholder returns through dividends and share repurchases. Despite economic headwinds, including inflation and geopolitical instability, Ecolab maintained its commitment to sustainability and innovation, aligning its business strategy with long-term global challenges. The acquisition of Purolite in December 2021 for $3.7 billion has been integrated and is contributing to the Life Sciences segment. The company is also executing on various restructuring plans aimed at enhancing efficiency and streamlining operations, with significant savings anticipated in the coming years. Ecolab's focus on providing water, hygiene, and infection prevention solutions positions it well to capitalize on increasing demand for sustainability and health-focused offerings.

Ecolab Inc. (ECL) announced on February 14, 2023, its fourth-quarter and full-year 2022 results, along with an expansion of its cost savings program. The company's earnings release and supplemental data, filed as exhibits, provide detailed financial performance for the period. Investors should note the company's updated restructuring charges related to an expanded cost savings program, which now expects to incur pre-tax charges of $195 million ($150 million after tax). These charges are primarily for severance and asset disposals and are expected to be completed by the end of 2024. This expanded program targets cost savings within the Institutional and Healthcare businesses in regions beyond Europe. While the specific financial metrics from the earnings release are not detailed in this 8-K filing itself, the report indicates that these results are available via attached exhibits (99.1 and 99.2) and will be published on Ecolab's website. The focus for investors in this filing is the significant restructuring initiative and its associated costs, which are aimed at improving the company's competitiveness, efficiency, and effectiveness in the long term.

Ecolab Inc. (ECL) announced on December 8, 2022, a significant addition to its Board of Directors with the appointment of Eric M. Green. Mr. Green brings extensive leadership experience, notably as President and CEO of West Pharmaceutical Services, Inc., and over two decades of experience at Sigma-Aldrich Corporation. His appointment is effective immediately, and he will serve on the Compensation and Human Capital Management Committee and the Governance Committee. This appointment signifies a strengthening of Ecolab's corporate governance and oversight. Investors can view Mr. Green's extensive background in the pharmaceutical and life sciences sectors as a valuable asset to Ecolab's strategic direction and executive compensation oversight. His participation in key board committees underscores the company's commitment to robust governance practices.

Ecolab Inc. (ECL) filed an 8-K on November 17, 2022, disclosing a key executive departure and related separation agreement. Timothy P. Mulhere, Executive Vice President – Special Initiatives – Institutional, will be leaving the company effective December 31, 2022. The filing details the terms of his separation agreement, which includes continued base salary through his departure date, a guaranteed minimum bonus for 2022, and approximately one year of severance payments. This event, while not directly impacting ongoing operations, is important for investors to note as it signifies a change in leadership within a specific division. The financial implications of Mr. Mulhere's departure are clearly outlined in the separation agreement, providing transparency on the costs associated with this transition. Investors should monitor any subsequent appointments or restructuring within the Institutional segment.

Ecolab Inc. (ECL) filed an 8-K on November 17, 2022, to report the completion of its offering of $500 million aggregate principal amount of 5.250% Notes due 2028. The issuance of these Notes represents a new direct financial obligation for the company. The proceeds from this offering are intended for general corporate purposes, which may include the repayment of existing commercial paper or other debt. This debt issuance signals the company's strategy to manage its capital structure and potentially refinance or consolidate existing obligations. Investors should note the terms of the Notes, including the 5.250% annual interest rate payable semi-annually and the maturity date of January 15, 2028. The Notes are redeemable at Ecolab's option. Furthermore, the Indenture governing these Notes includes provisions for a mandatory repurchase offer at 101% of the principal amount in the event of a change of control. Covenants within the Indenture also place certain limitations on the company's ability to incur additional liens, engage in sale and leaseback transactions, and transfer assets to unrestricted subsidiaries, providing some level of protection for noteholders.

Ecolab Inc. (ECL) filed an 8-K on November 9, 2022, reporting on a material definitive agreement and other events. The core of the filing is the company's entry into an Underwriting Agreement on November 7, 2022, to issue and sell $500 million in aggregate principal amount of 5.250% Notes due 2028. This debt offering was registered under a previously effective shelf registration statement. The agreement outlines customary representations, warranties, covenants, and indemnification provisions between Ecolab and the underwriters, led by BofA Securities, Citigroup Global Markets, and Goldman Sachs. The closing of this note offering is anticipated for November 17, 2022, contingent upon standard closing conditions. This filing primarily informs investors about Ecolab's financing activities and its continued access to capital markets.

Ecolab Inc. (ECL) reported its third quarter and nine-month results for the period ending September 29, 2022. The company demonstrated revenue growth, with reported net sales increasing by 10% year-over-year for the third quarter and 12% for the nine-month period. This growth was driven by a combination of pricing actions and volume increases across its segments, particularly in Global Industrial and Global Institutional & Specialty. However, the company faced challenges with increased cost of sales, primarily due to product cost inflation, which impacted gross margins. Despite these pressures, Ecolab managed its selling, general, and administrative expenses effectively, leading to an increase in reported operating income for the third quarter. Management highlighted the impact of foreign currency translation, which unfavorably affected reported results. Special charges and discrete tax items also played a role in year-over-year comparisons. Looking ahead, Ecolab is implementing cost-saving programs, including a new Europe cost savings initiative, and managing its capital structure through share repurchases and dividend payments. The company reaffirmed its commitment to strategic acquisitions and innovation to drive future growth while navigating a complex global economic environment characterized by inflation and geopolitical uncertainties.

Ecolab Inc. (ECL) announced a significant capital allocation decision via an 8-K filing on November 3, 2022, detailing the authorization of a new share repurchase program by its Board of Directors. The company plans to repurchase up to an additional 10,000,000 shares of its common stock. This action signals management's confidence in the company's financial health and its commitment to returning value to shareholders. The repurchase is expected to be executed through various market-based methods, including open market transactions and potentially accelerated share repurchase programs, offering flexibility in execution based on market conditions. This new authorization, along with remaining shares from a previous authorization, brings the total available for repurchase to 13,404,297 shares. The last increase in share repurchase authorization was in February 2015, making this a notable update to the company's capital return strategy. Investors should view this as a positive signal regarding Ecolab's ongoing assessment of its stock as an attractive investment and its strategy to manage its share count.

Ecolab Inc. (ECL) filed an 8-K report on November 1, 2022, primarily to announce its third-quarter 2022 earnings results and a new Europe cost savings program. While the specific financial details of the third quarter are not fully disclosed within this 8-K, the report indicates that the company has provided a press release and supplemental data for investors and analysts to review. These attached exhibits will contain the key performance indicators and financial metrics for the quarter ended September 30, 2022. In addition to the earnings announcement, Ecolab disclosed a significant restructuring initiative, the "Europe cost savings program," expected to conclude by mid-2024. This program is anticipated to incur pre-tax charges of $130 million, with a substantial portion ($60 million) recognized in the fourth quarter of 2022. These charges are primarily related to severance and asset disposals. Investors should note that these are forward-looking statements and actual results could differ due to various risks and uncertainties.

Ecolab Inc. (ECL) filed an 8-K on September 27, 2022, primarily announcing a significant executive leadership transition and related compensation adjustments. Timothy P. Mulhere is retiring from his role as executive vice president and president of Global Institutional and Specialty, effective October 1, 2022, with a full retirement by the end of 2022. This marks the end of a long tenure for a key executive. In parallel, Ecolab has appointed Darrell Brown as president and chief operating officer, effective October 1, 2022. Mr. Brown brings extensive experience within Ecolab, having previously led the Global Industrial Group and other international divisions. His promotion is accompanied by an increase in his annual base salary to $750,000 and his target annual cash incentive award opportunity to 100%. Additionally, CFO Scott Kirkland's compensation was adjusted, with his base salary increasing to $750,000 and his target annual cash incentive award opportunity to 100%, both effective October 1, 2022. These changes reflect the company's strategy for leadership continuity and executive compensation adjustments.